Tolerance.ca
Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.

Alzheimer’s drug approved in the UK, but it won’t be available on the NHS – here’s why

By Rahul Sidhu, PhD Candidate, Neuroscience, University of Sheffield
The UK’s drugs regulator – the MHRA – has approved the Alzheimer’s drug donanemab, but it won’t be available on the NHS.

The National Institute for Health and Care Excellence (Nice), which determines what treatments are available on the NHS, decided…The Conversation


Read complete article

© The Conversation -
Subscribe to Tolerance.ca


Follow us on ...
Facebook Twitter